Guangzhou Baiy | 600332 - Ebitda

Stock Price
22.76
Daily Change
-0.27 -1.17%
Monthly
-9.57%
Yearly
-12.02%
Q2 Forecast
22.49

Guangzhou Baiy reported CNY961.82M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Cipla INR 12.55B 6.4B Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Jiangsu Hengrui CNY 2.98B 890.87M Jun/2025
Kalbe Farma IDR 1.3T 18.7B Jun/2025
Richter Gedeon HUF 84.16B 8.44B Dec/2024
Sh Fosun Pharma CNY 1.69B 17.13M Jun/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025